Are You Making The Most Of Your Depression Treatment Advancements?
Depression Treatment Advancements
Researchers are constantly striving to improve the treatment of depression. This special Research in Context feature will examine some of these depression treatment advancements.
Psychotherapy can help alleviate depression symptoms by teaching a person how to manage negative feelings and thoughts. Talk therapy can be performed one-on-one with a health professional or in a group setting.
Precision mental healthcare
The term "precision" refers to the ability to bring more precision or precision to prevention, diagnosis and treatment methods. In the case of mental health, this means many different approaches, from psychotherapy to medications. Many of these approaches concentrate on the symptoms of the disorder instead of the root cause. This can lead to treatments which only reduce symptoms, but not address the root causes of mental illness.
Precision mental healthcare is rapidly advancing. It's similar to the method that is used in other areas that include continuous monitoring of important indicators (e.g. fever or blood pressure) into clinical practice. It also involves combining multiple data sets and applying machine learning to help doctors comprehend the specific requirements of a patient and develop more efficient treatments.
One example of precision psychiatry is the use of EEG to monitor brain activity and help doctors determine whether a patient is able to engage in cognitive behavior therapy. A new class of drugs referred to as NMDA receptor inhibitors may reduce symptoms of depression by preventing the neurotransmitter glutamate from reaching certain brain cell. The test can be used to detect interactions between genes and drugs, and to prevent undesirable effects.
Additionally, a variety of companies are looking into digital precision psychiatry, which makes use of objective digital technologies to monitor patients remotely and collect real-time data that aids in guiding the treatment they receive. One example is that a company is using artificial intelligence to monitor adherence and optimize medication dosages for their patients suffering from depression. These kinds of solutions are likely to dramatically improve accessibility and effectiveness of mental health services and increase the patients' adherence to treatment.
Furthermore, digital precision psychiatry can help overcome barriers to treatment for people suffering from mental illness, particularly those in the workforce. For example one Johnson & Johnson initiative in Singapore is working with other organizations to support the re-integration of workers in recovery from depression into their work environments and communities. This can help them maintain their job, which is vital for the recovery of mental health.
Medication
Many people who suffer from depression find that medication relieves their symptoms. This is particularly relevant if the symptoms are severe or incapacitating. Antidepressants restore the balance of neurotransmitters in the brain, which are chemical messengers that regulate mood and emotional state. Most current antidepressants target one of these neurotransmitters, boosting levels of serotonin, norepinephrine and dopamine. Selective serotonin reuptake inhibitors (SSRIs), like Prozac and Zoloft increase the levels of serotonin, a chemical in the brain. The SNRIs like Cymbalta, Effexor and Cymbalta focus on both norepinephrine as well as dopamine. Monoamine oxidase inhibitors such as Wellbutrin target only dopamine and norepinephrine.
The majority of doctors prescribe antidepressants to treat depression as a first treatment, in addition to talk therapy. Some of these treatments include cognitive therapy that helps improve your mood and thoughts by teaching specific skills or interpersonal psychotherapy, which focuses on improving relationships. Other therapies, like electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS) are also known to have been proved to be effective in treating depression.
However, some people do not respond to the initial medication that doctors prescribe. Up to a third of patients suffering from depression don't see any improvement from their first medication and about 40 percent who start taking antidepressants stop them within three months. The good news is that recent research has allowed doctors to predict which type of medication will work best for each individual, utilizing blood or MRI tests to determine which receptors are the most affected by the depression.

Medication has improved in recent years with more options and better dosages to minimize adverse effects. For instance, antidepressants that are more recent such as esketamine (Spravato), Brexanolone (Auvelity) and Nefazodone (Sertraline) work to rapidly alleviate depression symptoms through targeting glutamate activity in the brain.
Clinical trials are being conducted on different medications that could change the way they are used. Vorapaxar, a drug which is currently being tested in humans, targets a different brain region that's associated with depression, by blocking NMDA receptors. It's anticipated to be available by 2024. Another drug that has shown promise is a combination of ketamine and bupropion, which could be more effective at treating treatment-resistant depression.
Psychotherapy
Researchers in psychiatry have identified certain factors that can contribute to depression. These include imbalances in the neurotransmitters serotonin as well as norepinephrine. These chemicals are essential in regulating mood and emotions, as well as the overall function of the brain. Medications such as selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors are the main treatment options. They can alleviate many symptoms of depression such as depression, fatigue and sleep issues. They do not come without side effects, which can make them unsuitable to some people.
Psychotherapy can address the root causes and help individuals cope with depression. A variety of therapies have been proven to decrease symptoms, such as cognitive behavioral therapy and ketamine infusion therapy. Psychotherapy can help people to develop a healthier way of coping and help them manage stressors. However, access to psychotherapy can be restricted by costs or scheduling restrictions, as well as a shortage of mental health professionals. The recent rise of Telehealth services has made it easier to some people.
Finding the best treatment combination is essential to overcome depression. A single medication may not be enough to relieve all of your symptoms. It can take 6 to 12 weeks before you know whether a medication is working. There are a variety of alternatives to nonpharmacologic treatment, such as transcranial magnetic stimulation that is repeated and vagus nervous stimulation. These therapies use electromagnetic fields in order to improve mood and increase the brain's chemical.
It's crucial to collaborate closely with your doctor, regardless of whether you're looking to try therapy or medication. Discuss your feelings and thoughts as well as the potential risks and adverse effects that come with each choice. Find a provider that can meet your requirements in case you're having difficulty establishing trust with your doctor or therapist. A service that offers a free trial period could be a great option, as it offers you the opportunity to try different methods before committing. Eventually, you'll find the treatment that is most effective for you and helps you feel your most at your best.
Brain stimulation
In just a few years, scientists have come up with new methods to target specific regions of the brain, and rapidly alter the way they function. These techniques can be used to treat depression and other mental disorders, as well as a variety of physical diseases.
rTMS is a technique that utilizes electromagnetic pulses to stimulate brain activity. It is similar to magnetic pulses used in MRIs but not sufficient to trigger seizures. The technique is achieved by stimulating a specific area of the brain with a painless magnet. The pulses alter the way that your brain processes and help you feel better. The therapy takes only 3.5 minutes, and does not disrupt your daily routine. You might experience a mild headache afterwards.
Another treatment involves implanting electrodes in the brain to send out painless electrical impulses. This treatment is also known as deep transcranial magnetic stimulation (deep TMS), and it's been utilized to treat OCD and to quit smoking cigarettes. It's still being studied to help treat depression, but early studies suggest it can reduce depressive symptoms in a few people. The mechanism of this treatment isn't fully understood, but it seems to be able to alter the balance of certain neurotransmitters.
Other noninvasive brain stimulation techniques are also improving. For example the results of a recent study revealed that patients suffering from severe depression who were not tolerant to antidepressants responded to the treatment with magnetic pulses called SAINT. It's personalized to the individual's anatomy in the brain and uses high-dose patterns of magnetic pulses. The treatment can be delivered within a couple of hours, whereas previous treatments required daily sessions for months or weeks.
Researchers used fMRI technology to pinpoint precisely the brain region that was being stimulated by every patient. They also studied minute variations in the stimulation of the various brain regions, which helped determine the direction of the signals. They found that in depressed people the brain's anterior cingulate cortex sent signals to an area called the subgenual cingulate cortex. However, depression treatment for adults were frequently misdirected and the more severe the depression, the more of these signals that were not directed in the right direction were.